FDA Inspection 1243362 — Baxter Healthcare Corporation
The FDA completed an inspection of Baxter Healthcare Corporation on Aug 1, 2024 in Round Lake, IL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Aug 1, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Round Lake, IL (United States)